
In recent years Yale University has worked to move research into the commercial sector. The Yale Office of Cooperative Research (OCR) works with Yale researchers to identify inventions that may ultimately become commercial and consumer products and services. Yale OCR staff also engages in industrial partnerships to license Yale inventions.

Yale currently is helping develop 6 new companies: Axomedis, New Haven Pharmaceuticals, Advanced Orthopedic Technologies, 3primiR, CBT4CBT and CardioPhotonics. This is in addition to existing successful relationships with Vion, Achillion, Proteolix, Helix Therapeutics, Rib-X, Shire, Pharmasset and Tigris.